$1.64 Million Revenue Medicare Certified Hospice and Home Health Agency Serving Clients in Northern California

Why It Matters

The acquisition offers immediate entry into a growing home‑care market with proven Medicare revenue streams and a stable, multi‑payer client base, positioning buyers for scalable growth in a high‑demand region.

Key Takeaways

• Medicare-certified hospice and home health agency listed for sale
• 2025 revenue $1.64M, EBITDA $238,770
• Payer mix: 40% Medicare, 25% Kaiser, 25% SantaClara, 10% other
• Serves six Northern California counties including Alameda and Santa Clara
• Asking price $995k, excludes cash, receivables, working capital

Pulse Analysis

The hospice and home health sector is experiencing accelerated demand as the U.S. population ages and Medicare expands coverage for post‑acute services. Northern California, with its high concentration of retirees and tech‑driven health insurers, provides a fertile environment for providers that can navigate complex reimbursement models. A Medicare certification not only validates quality standards but also unlocks a reliable revenue pipeline, making such agencies attractive assets for investors seeking stable cash flows.

Financially, the agency demonstrates consistent top‑line growth since its 2016 launch, culminating in $1.64 million of gross revenue and a healthy adjusted EBITDA margin of roughly 14.5% in 2025. The diversified payer mix—40% Medicare, 25% Kaiser, 25% Santa Clara Family Health Plan, and 10% commercial—mitigates concentration risk and reflects strong relationships with both public and private insurers. Valuation at $995,000, excluding working capital, suggests a purchase price multiple near 4.2x EBITDA, which is competitive given the sector’s typical 5‑7x range, especially when factoring in the agency’s established staff and operational infrastructure.

Strategically, the transaction offers buyers a turnkey platform with a committed workforce slated to remain post‑sale, reducing integration friction. The owner’s willingness to support a brief transition ensures continuity of care and preserves referral networks. Prospective owners can leverage the agency’s existing service portfolio—ranging from wound care to hospice—to cross‑sell ancillary therapies, expand into adjacent counties, or integrate with larger health systems seeking to bolster their home‑based care capabilities. This acquisition thus represents a compelling opportunity to capture market share in a high‑growth, reimbursement‑rich segment of the healthcare industry.